| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/03/1996 | EP0643835A4 Htlv-i/htlv-ii assay and method. |
| 04/03/1996 | EP0396608B1 Mutated subtilisin genes |
| 04/03/1996 | CN1119877A Novel pesticidal proteins and strains |
| 04/03/1996 | CN1119876A Regulated transcription of targeted genes and other biological events |
| 04/03/1996 | CN1119830A Antisense inhibition of C-MYC to modulate the proliferation of smooth muscle cells |
| 04/03/1996 | CN1119677A Molecular guide medicine gene clone containing IL_II and toxin gene fragment and expressing |
| 04/03/1996 | CN1031465C DNA clones coding for polypeptides exhibiting human graulocyte macrophage and eosinophil cellular growth factor activity |
| 04/02/1996 | US5504198 Recombinant dna molecule coding for monoclonal antibody; diagnosis, treatment and prevention of disease |
| 04/02/1996 | US5504008 Method for protein N-myristoylation |
| 04/02/1996 | US5504005 Recombinant mycobacterial vaccine |
| 04/02/1996 | US5503993 Expressing and secreting mature human serum albumin by yeast transformed by recombinant dna comprising modified signal peptide gene which encodes modified signal peptide, promoter, terminator linked operably in proper reading frame |
| 04/02/1996 | US5503991 Vectors for use in filamentous fungi |
| 04/02/1996 | US5503987 Immunoassay for metallic cations and small organic molecules |
| 04/02/1996 | US5503983 Incubating eluate with solid support precoated with antibodies washing, incubating second composition of antibodies with said solid support, washing, detecting antibodies bound to solid support |
| 04/02/1996 | US5503981 Isolation of fetal cells from maternal blood to enable prenatal diagnosis |
| 04/02/1996 | US5503976 DNA sequences coding for the DR β-chain locus of the human lymphocyte antigen complex and diagnostic typing processes and products related thereto |
| 04/02/1996 | US5503847 Hydrocolloid wound gel |
| 04/02/1996 | US5503828 Alpha interferon composition and method for its production from human peripheral blood leukocytes |
| 04/02/1996 | CA2066370C Yield when disulfide-bonded proteins are secreted |
| 03/28/1996 | WO1996009408A1 Human galactokinase gene |
| 03/28/1996 | WO1996009397A1 Gene encoding carboxypeptidase of aspergillus niger |
| 03/28/1996 | WO1996009396A1 Calcium free subtilisin mutants |
| 03/28/1996 | WO1996009390A2 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
| 03/28/1996 | WO1996009389A2 Recombinant macrophage migration inhibitory factor; expression in escherichia coli and purification of recombinant protein |
| 03/28/1996 | WO1996009386A2 Allelic variation of the serotonin 5ht2c receptor |
| 03/28/1996 | WO1996009385A1 Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 03/28/1996 | WO1996009382A1 gp130 LACKING THE TRANSMEMBRANE DOMAIN |
| 03/28/1996 | WO1996009377A1 Transgenic animals expressing human coagulation factor viii and von willebrand factor |
| 03/28/1996 | WO1996009375A1 Dna encoding human papillomavirus type 6a |
| 03/28/1996 | WO1996009374A1 Human galactokinase gene |
| 03/28/1996 | WO1996009321A1 Broadly reactive opsonic antibodies reactive with common staphylococcal antigens |
| 03/28/1996 | WO1996009320A1 Antigenic polypeptide of chlamydia pneumoniae |
| 03/28/1996 | WO1996009311A1 Human transcription factor iia |
| 03/28/1996 | WO1996007738A3 Modified human c3 proteins |
| 03/28/1996 | WO1996005314A3 Protein toxins active against lepidopteran pests |
| 03/28/1996 | DE4441197C1 Schizosaccharomyces pombe expression plasmids |
| 03/28/1996 | CA2199748A1 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
| 03/28/1996 | CA2199470A1 Allelic variation of the serotonin 5ht2c receptor |
| 03/27/1996 | EP0702793A1 Anti-cd3 antibody-aminodextran conjugates for induction of t-cell activation and proliferation |
| 03/27/1996 | EP0702730A1 Germline mutations in the mts gene and method for detecting predisposition to cancer at the mts gene |
| 03/27/1996 | EP0702726A1 Immunoassay reagents and methods for detecting brequinar and analogs |
| 03/27/1996 | EP0702725A1 Method for recombinant production of biologically active polypeptides |
| 03/27/1996 | EP0702724A1 Mengovirus as a vector for expression of foreign polypeptides |
| 03/27/1996 | EP0702721A1 Process for producing fusion proteins comprising scfv fragments by a transformed mould |
| 03/27/1996 | EP0702695A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1) |
| 03/27/1996 | EP0702689A1 Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids |
| 03/27/1996 | EP0702566A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 03/27/1996 | EP0702516A1 Genetic immunization with cationic lipids |
| 03/27/1996 | EP0483224B1 Inducible expression vectors |
| 03/27/1996 | CN1119459A Process for preparing cancer vaccines |
| 03/27/1996 | CN1119457A Bone stimulating factor |
| 03/27/1996 | CN1119121A Crystalline interleukin-4 |
| 03/27/1996 | CA2159044A1 Method of quantitating nucleic acids |
| 03/26/1996 | US5502167 CDR grafted humanised chimeric T-cell antibodies |
| 03/26/1996 | US5502033 Antimicrobial polypeptide compound a pharmaceutical composition comprising the same, and a method for treating infectious diseases |
| 03/26/1996 | US5501988 Cancer detection |
| 03/26/1996 | US5501983 Assay of free and complexed prostate-specific antigen |
| 03/26/1996 | US5501979 Herpes simplex virus type I expression vector |
| 03/26/1996 | US5501975 Transformed host cell, dibasic processing endoprotease, improved yield of correctly folded proteins |
| 03/26/1996 | US5501970 Nucleotide sequences coding for ribosome inactivating proteins |
| 03/26/1996 | US5501969 Bone disorders, antitumor |
| 03/26/1996 | US5501854 Comprising first and second portions having affinities for cellular target and bioactive molecules respectively; therapy, medical diagnosis |
| 03/26/1996 | US5501853 Peptide plasminogen activators |
| 03/26/1996 | CA1338183C Cyclic peptolides |
| 03/21/1996 | WO1996008574A1 Novel implant and novel vector for the treatment of acquired diseases |
| 03/21/1996 | WO1996008572A1 Method for the production of recombinant proteins, plasmids and modified cells |
| 03/21/1996 | WO1996008570A1 Expression and export technology of proteins as immunofusins |
| 03/21/1996 | WO1996008569A2 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 03/21/1996 | WO1996008564A1 Humanised antibody to integrin chain beta-1 |
| 03/21/1996 | WO1996008563A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 03/21/1996 | WO1996008516A1 PORCINE ANTIBODIES TO TNF-α(ALPHA) |
| 03/21/1996 | WO1996008515A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 03/21/1996 | WO1996008514A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
| 03/21/1996 | WO1996008513A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same |
| 03/21/1996 | WO1996008511A1 ACTIVE INDUCTION OR PASSIVE IMMUNIZATION OF ANTI-gp48 ANTIBODIES AND ISOLATED gp48 PROTEIN |
| 03/21/1996 | WO1996008510A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR |
| 03/21/1996 | WO1996008506A1 Phosphorus-32 labeling of antibodies for cancer therapy |
| 03/21/1996 | WO1996008272A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 03/21/1996 | WO1996008269A1 Inhibition of human rotavirus infection |
| 03/21/1996 | WO1996008263A1 Intracellular delivery of chemical agents to a specific cell type |
| 03/21/1996 | WO1995020039A3 Customized proteases with altered transacylation activity |
| 03/21/1996 | DE4435485C1 Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor Process for the recovery of high purity von Willebrand factor |
| 03/21/1996 | CA2200088A1 Phosphorus-32 labeling of antibodies for cancer therapy |
| 03/21/1996 | CA2200087A1 Active induction or passive immunization of anti-gp48 antibodies and isolated gp48 protein |
| 03/21/1996 | CA2199867A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 03/21/1996 | CA2199749A1 Humanised antibody to integrin chain beta-1 |
| 03/21/1996 | CA2199740A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor |
| 03/21/1996 | CA2199719A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
| 03/21/1996 | CA2199707A1 Inhibition of human rotavirus infection |
| 03/21/1996 | CA2198361A1 Intracellular delivery of chemical agents to a specific cell type |
| 03/20/1996 | EP0702084A1 Recombinant retroviruses |
| 03/20/1996 | EP0702083A2 Polypeptides and fusion proteins that contain the UL57 open reading frame or the C-terminus of tegument protein pp150 from HCMV, corresponding oligonucleotides and diagnostic test kits |
| 03/20/1996 | EP0702082A1 Amino acid sequences of anti-idiotypic antibodies against anti-cancer human monoclonal antibody, and dna base sequences encoding those sequences |
| 03/20/1996 | EP0701818A2 Therapeutic methods using catalytic antibodies |
| 03/20/1996 | EP0701696A1 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays |
| 03/20/1996 | EP0701628A1 Process for screening substances having a modulating effect on an interleukine-5-receptor-dependent cellular signal transmission path |
| 03/20/1996 | EP0701616A1 Multicistronic expression of recombinant genes in bacterial cells |
| 03/20/1996 | EP0701612A1 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS |
| 03/20/1996 | EP0701611A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
| 03/20/1996 | EP0701610A1 Dna coding for the human thyrotropin-releasing hormone receptor |